What is Janux Therapeutics's operating lease ROU assets?

Janux Therapeutics (JANX) reported operating lease ROU assets of $17.87M in Q1 2026.

How has Janux Therapeutics's operating lease ROU assets changed year-over-year?

Janux Therapeutics's operating lease ROU assets decreased by 5.3% year-over-year, from $18.88M to $17.87M.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Janux Therapeutics JANX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

XencorXNCR

$36.82M-2.2%

Vor BiopharmaVOR

$2.83M-91.6%

Cullinan Therapeutics, Inc.CGEM

$2.44M+57.2%

ImmunomeIMNM

$2.83M-32.1%

CRISPR TherapeuticsCRSP

$128.67M-8.3%

Inhibrx Biosciences, Inc.INBX

10.2%0.0pp

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's operating lease ROU assets?: Janux Therapeutics (JANX) reported operating lease ROU assets of $17.87M in Q1 2026.
How has Janux Therapeutics's operating lease ROU assets changed year-over-year?: Janux Therapeutics's operating lease ROU assets decreased by 5.3% year-over-year, from $18.88M to $17.87M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.